Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.09% | 203.00 | 1.2% | $406.48m | |
| GILD | Gilead Sciences, Inc. | 0.51% | 73.15 | 0.9% | $396.47m | |
| CELG | Celgene Corporation | 0.67% | 87.78 | 1.2% | $341.39m | |
| BIIB | Biogen Inc. | 0.25% | 335.25 | 1.2% | $274.66m | |
| ILMN | Illumina, Inc. | 1.42% | 352.16 | 3.5% | $255.83m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.14% | 385.97 | 2.6% | $209.96m | |
| EXAS | Exact Sciences Corporation | -1.79% | 72.02 | 25.3% | $195.13m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.59% | 176.83 | 1.9% | $160.81m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.93% | 153.76 | 16.4% | $126.02m | |
| A | Agilent Technologies, Inc. | -0.51% | 68.73 | 1.5% | $120.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.51% | 119.59 | 2.0% | $109.12m | |
| NKTR | Nektar Therapeutics | 0.57% | 58.64 | 5.6% | $96.51m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 0.42% | 93.75 | 9.7% | $96.22m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.00% | 99.13 | 4.4% | $91.59m | |
| INCY | Incyte Corporation | 0.73% | 67.51 | 2.5% | $88.35m |
Company Profile
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey Zarur, and Gilad Hayeem in March 2013 and is headquartered in Cambridge, MA.